3 results
Primary: To characterize the safety and tolerability of PDR001 in combination with LCL161, everolimus, HDM201, QBM076 or panobinostat and to identify recommended doses and schedules for future studies.Secondary: To characterize changes in the immune…
The primary outcome is the first attempt success ratio of peripheral intravenous catheter placement with the use of the Veinplicity®, when compared to the traditional landmark technique, in patients with a medium-risk profile according to the A-DIVA…
Protocol page 33:The purpose of the study is to provide data demonstrating the safety and effectiveness of the PFAsystem for the treatment of atrial fibrillation. The study will also provide first in human insights intoclinical safety and device…